Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B

Peginterferon Alfa ◽

Phase Iv

Evidence for the efficacy of peginterferon alfa-2a (40 KD) (PEGASYS) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors

Journal of Hepatology ◽

10.1016/s0168-8278(02)80017-4 ◽

2002 ◽

Vol 36 ◽

pp. 8 ◽

Cited By ~ 4

Author(s):

W.Graham E. Cooksley ◽

Teerha Piratvisuth ◽

Yuan-Jen Wang ◽

Varocha Mahachai ◽

You-Chen Chao ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Baseline Factors ◽

Efficacy and safety of peginterferon alfa-2a in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B

Antiviral Therapy ◽

10.3851/imp2664 ◽

2013 ◽

Vol 18 (6) ◽

pp. 765-773 ◽

Cited By ~ 4

Author(s):

Dong Jin Suh ◽

Han Chu Lee ◽

Kwan Soo Byun ◽

Mong Cho ◽

Young Oh Kweon ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Efficacy And Safety ◽

PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA

Value in Health ◽

10.1016/s1098-3015(11)72842-x ◽

2010 ◽

Vol 13 (7) ◽

pp. A438

Author(s):

W Chen

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

Yearbook of Gastroenterology ◽

10.1016/s0739-5930(08)70447-1 ◽

2006 ◽

Vol 2006 ◽

pp. 275-277 ◽

Cited By ~ 1

Author(s):

M.S. Campbell

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

421 A new bio-mathematical model to describe the dynamics of HBV-DNA and infected hepatocytes in HBEAG-negative/anti-HBE-positive chronic hepatitis B patients treated with peginterferon alfa-2A (40KD) (PEGASYS®), lamivudine, or PEGASYS® plus lamivudine combin

Journal of Hepatology ◽

10.1016/s0168-8278(04)90421-7 ◽

2004 ◽

Vol 40 ◽

pp. 125 ◽

Cited By ~ 1

Author(s):

P. Colombatto ◽

R. Bizzarri ◽

L. Civitano ◽

F. Oliveri ◽

F. Bonino ◽

...

Keyword(s):

Mathematical Model ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Hbv Dna ◽

Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa

Gastroenterology ◽

10.1053/j.gastro.2009.08.061 ◽

2009 ◽

Vol 137 (6) ◽

pp. 2002-2009 ◽

Cited By ~ 250

Author(s):

Erik H.C.J. Buster ◽

Bettina E. Hansen ◽

George K.K. Lau ◽

Teerha Piratvisuth ◽

Stefan Zeuzem ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Hepatitis B E Antigen ◽

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

Hepatology ◽

10.1002/hep.23844 ◽

2010 ◽

Vol 52 (4) ◽

pp. 1251-1257 ◽

Cited By ~ 201

Author(s):

Milan J. Sonneveld ◽

Vincent Rijckborst ◽

Charles A. B. Boucher ◽

Bettina E. Hansen ◽

Harry L. A. Janssen

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Surface Antigen ◽

Hepatitis B Surface Antigen ◽

Sustained Response ◽

Hepatitis B E Antigen ◽

Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2009.01178.x ◽

2010 ◽

Vol 17 (4) ◽

pp. 298-304 ◽

Cited By ~ 31

Author(s):

L. Wang ◽

F. Liu ◽

Y.-D. Liu ◽

X.-Y. Li ◽

J.-B. Wang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Clinical Study ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Prospective Clinical Study ◽

Lamivudine Treatment ◽

Hepatitis B E Antigen ◽

Positive Chronic Hepatitis

Treatment with peginterferon alfa-2a (40KD) (PEGASYS®) results in improved rates of response compared to conventional interferon in patients with HBEAG positive chronic hepatitis B harboring HBV genotypes B or ‘difficult-to-treat’ genotype C

Journal of Hepatology ◽

10.1016/s0168-8278(03)80483-x ◽

2003 ◽

Vol 38 ◽

pp. 25 ◽

Cited By ~ 2

Author(s):

W.G.E. Cooksley ◽

M.-Y. Lai ◽

T. Piratvisuth ◽

Y.-J. Wang ◽

V. Mahachai ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Hbv Genotypes ◽

Genotype C ◽

Conventional Interferon ◽

Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

Hepatology ◽

10.1002/hep.23568 ◽

2010 ◽

Vol 51 (6) ◽

pp. 1945-1953 ◽

Cited By ~ 74

Author(s):

Vincent Wai-Sun Wong ◽

Grace Lai-Hung Wong ◽

Kenneth Kar-Lung Yan ◽

Angel Mei-Ling Chim ◽

Hoi-Yun Chan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Hepatitis B E Antigen ◽